SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
19-Jul-24 8:29 AM View: | Esperion Therapeutics, Inc. (ESPR) | 17-Jul-24 | Sale | 917 | $2.60 | $2,383.28 | (< 1%) 273.78K to 272.86K | |
20-Jun-24 4:20 PM View: | Esperion Therapeutics, Inc. (ESPR) | 18-Jun-24 | Sale | 3,285 | $2.87 | $9,418.10 | (1%) 277.06K to 273.78K | |
15-Mar-24 4:34 PM View: | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-24 | Grant | 150,000 | -- | -- | 118% 127.06K to 277.06K | |
20-Apr-23 4:11 PM View: | Esperion Therapeutics, Inc. (ESPR) | 19-Apr-23 | Sale | 938 | $1.27 | $1,192.20 | (< 1%) 128.0K to 127.06K | |
20-Mar-23 4:19 PM View: | Esperion Therapeutics, Inc. (ESPR) | 17-Mar-23 | Sale | 3,808 | $1.78 | $6,785.48 | (3%) 131.81K to 128.0K | |
15-Mar-23 9:20 AM View: | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-23 | Grant | 28,750 | -- | -- | 28% 103.06K to 131.81K | |
08-Mar-23 4:20 PM View: | Esperion Therapeutics, Inc. (ESPR) | 07-Mar-23 | Private Sale | 3,884 | $5.07 | $19,672.50 | (4%) 106.94K to 103.06K | |
19-Jan-23 4:58 PM View: | Esperion Therapeutics, Inc. (ESPR) | 18-Jan-23 | Private Sale | 1,191 | $6.99 | $8,319.13 | (1%) 108.14K to 106.94K | |
19-Oct-22 4:13 PM View: | Esperion Therapeutics, Inc. (ESPR) | 18-Oct-22 | Private Sale | 942 | $7.69 | $7,242.10 | (< 1%) 109.08K to 108.14K | |
20-Jul-22 4:27 PM View: | Esperion Therapeutics, Inc. (ESPR) | 19-Jul-22 | Private Sale | 3,901 | $6.55 | $25,551.60 | (3%) 112.98K to 109.08K | |
16-Mar-22 5:10 PM View: | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-22 | Grant | 28,000 | -- | -- | 33% 84.98K to 112.98K | |
01-Nov-21 4:48 PM View: | Esperion Therapeutics, Inc. (ESPR) | 29-Oct-21 | Grant | 22,450 | -- | -- | 36% 62.53K to 84.98K | |
08-Jul-21 7:30 AM View: | Esperion Therapeutics, Inc. (ESPR) | 28-Jun-21 | Grant | 62,528 | -- | -- | 100% 0 to 62.53K |